You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Anagrelide hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for anagrelide hydrochloride and what is the scope of freedom to operate?

Anagrelide hydrochloride is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Barr, Chartwell Rx, Impax Labs, Ivax Sub Teva Pharms, Natco Pharma Usa, Rising, Roxane, Torrent, and Watson Labs, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for anagrelide hydrochloride. Four suppliers are listed for this compound.

Summary for anagrelide hydrochloride
Recent Clinical Trials for anagrelide hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CelgenePhase 3
PharmaEssentiaPhase 3
Brightech InternationalPhase 3

See all anagrelide hydrochloride clinical trials

Pharmacology for anagrelide hydrochloride

US Patents and Regulatory Information for anagrelide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076468-002 Apr 18, 2005 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Sub Teva Pharms ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076468-001 Apr 18, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Impax Labs ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076910-002 Apr 18, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Natco Pharma Usa ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076811-001 Apr 18, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa AGRYLIN anagrelide hydrochloride CAPSULE;ORAL 020333-002 Mar 14, 1997 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076417-001 Apr 18, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roxane ANAGRELIDE HYDROCHLORIDE anagrelide hydrochloride CAPSULE;ORAL 076489-002 Apr 18, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.